Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients

Clinical trial NCT05660811 · UNKNOWN

Trial details

NCT number: NCT05660811
Sponsor: National Institute of Cardiology, Warsaw, Poland
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2022-09-28
Primary completion: 2026-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.